ArticleEndocrine, metabolic & immune disorders drug targets2026
Relative Fat Mass Associated with Hyperuricemia in Adults: A Cross-Sectional Study.
Article in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Relative Fat Mass and Psoriasis Risk: Evidence from NHANES 2009-2014.Journal of multidisciplinary healthcare · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsThere is a close relationship between obesity and hyperuricemia. Relative Fat Mass (RFM) is considered a new indicator for evaluating obesity. We aim to explore the relationship between RFM and the risk of hyperuricemia in adults.
methodsThis cross-sectional study included adult participants from the 2007-2018 National Health and Nutrition Examination Survey (NHANES). The RFM was calculated as: RFM =64 - (20 × height/waist circumference) + (12 × sex), where sex is defined as 0 for men and 1 for women. Hyperuricemia was confirmed by using serum uric acid (SUA) levels ≥ 7 mg/dL in men and ≥ 6 mg/dL in women. The relationship between RFM and the risk of hyperuricemia was thoroughly investigated.
resultsA total of 29369 participants were enrolled in this study. The RFM levels in the hyperuricemia group were higher than those in the non-hyperuricemia group (P < 0.01). Logistic and linear regression indicated that RFM levels were positively associated with the risk of hyperuricemia (OR=1.08, 95% CI: 1.05-1.11, P < 0.001) and SUA levels (β=0.04, 95% CI: 0.03-0.05, P < 0.001). The relationship remained consistent across subgroups. Smooth curve fitting showed a nonlinear relationship, with an inflection point at 34.22. Above this threshold, the link between RFM levels and hyperuricemia was found to be more remarkable.
conclusionHigher RFM is associated with an increased risk of hyperuricemia. RFM could act as a cost-efficient and straightforward measure for hyperuricemia risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.